Medicare Announces Price Cuts For 15 Drugs— Novo Nordisk's Wegovy And Ozempic To Cost $274 A Month - AstraZeneca (NASDAQ:AZN), Eli Lilly (NYSE:LLY)

The U.S. Centers for Medicare and Medicaid Services (CMS) on Tuesday announced that it has secured lower prices for 15 of its highest‑cost medications, resulting in substantial annual savings on prescription expenses.Drug Price Reductions Under Biden’s IRA Now Include Weight-Loss DrugsThe new prices will take effect in 2027, and the negotiated prices include a monthly cost of $274 for Novo Nordisk’s (NYSE:NVO) popular GLP-1 drug, semaglutide, sold as Wegovy, Ozempic, and Rybelsus.Other drugs that saw signif ...